Results 211 to 220 of about 409,422 (240)
Some of the next articles are maybe not open access.
Malignant Pleural Mesothelioma
Current Oncology Reports, 2011Malignant pleural mesothelioma (MPM) is a relatively rare thoracic malignancy accounting for about 2000-3000 new cases per year. This cancer has been increasing in incidence and is strongly associated with asbestos exposure. Also, it is characterized by insidious growth and clinical presentation at an advanced stage of disease.
Siva, Raja +2 more
openaire +2 more sources
Malignant Mesothelioma of the Pleura
Diseases of the Chest, 1956SUMMARY A case of a malignant mesothelioma is described starting in the diaphragmatic portion of the pleura and invading the left hemidiaphragm and the peritoneal cavity. Malignant pleural tumor is a definite clinical entity even if its pathological classification remains a matter of speculation. Persistent or recurrent discomfort from one hemithorax
openaire +2 more sources
Chemotherapy for malignant mesothelioma
Lung Cancer, 20050 d er to identify single drugs or combinations that how any activity in malignant pleural mesotheioma (MPM). In general, the reported level of acivity of these drugs was low, for which different easons could be given. Many of the phase II studies ave been poorly designed with too few patients nd many studies did not have standard review of he ...
openaire +2 more sources
Malignant pleural mesothelioma
Current Treatment Options in Oncology, 2000Despite innumerable trials of surgery, radiotherapy, and countless chemotherapeutic drugs, it is unclear whether any intervention has had a significant impact on more than a few highly selected patients with malignant pleural mesothelioma. Because most patients die of respiratory failure from extensive disease progression in the thorax, treatment ...
openaire +2 more sources
Malignant mesothelioma in a lamb
Veterinary Record, 1981P J, Brown, A D, Weaver
openaire +2 more sources
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Ca-A Cancer Journal for Clinicians, 2019Emanuela Taioli +2 more
exaly

